Objective. Congenital deficiency of the principal boundary lubricant in cartilage (i.e., lubricin, encoded by the gene PRG4) increases joint friction and causes progressive joint failure. This study was undertaken to determine whether restoring lubricin expression in a mouse model would prevent, delay, or reverse the disease process caused by congenital deficiency.
Methods. Using genetically engineered lubricindeficient mice, we restored gene function before conception or at ages 3 weeks, 2 months, or 6 months after birth. The effect of restoring gene function (i.e., expression of lubricin) on the tibiofemoral patellar joints of mice was evaluated histologically and by ex vivo biomechanical testing.
Results. Restoring gene function in mice prior to conception prevented joint disease. In 3-week-old mice, restoring gene function improved, but did not normalize, histologic features of the articular cartilage and whole-joint friction. In addition, cyclic loading of the joints produced fewer activated caspase 3-containing chondrocytes when lubricin expression was restored, as compared to that in littermate mice whose gene function was not restored (nonrestored controls). Restoration of lubricin expression in 2-month-old or 6-monthold mice had no beneficial effect on histopathologic cartilage damage, extent of whole-joint friction, or activation of caspase 3 when compared to nonrestored controls.
Conclusion. When boundary lubrication is congenitally deficient and cartilage becomes damaged, the window of opportunity for restoring lubrication and slowing disease progression is limited.
In order to develop successful strategies for treating disease, it is important to know whether and when features of disease can be prevented, delayed, or reversed. These considerations are relevant in the management of patients with congenital and acquired joint diseases. For example, nearly 50% of individuals with anterior cruciate ligament (ACL) injuries will develop signs and symptoms of arthritis within 15 years following their injury, independent of whether the injured joint has been surgically stabilized (1) . This observation suggests that either it is not possible to prevent progressive joint damage following many ACL injuries or current treatment strategies are inadequate. Determining whether joint damage can be prevented or reversed, and identifying critical windows of opportunity for doing so, will be essential for providing optimal care and controlling health care costs.
Insights into processes involved in joint injury and repair may come from the study of patients with the autoSupported by the NIH (grant AR-050180). somal recessive disease camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome and from animal models of this disease. CACP is a precocious joint failure disorder caused by genetic deficiency of lubricin (encoded by PRG4) (2), the major boundary lubricant in articulating joints (3) . During development, lubricin is expressed by surface chondrocytes as soon as the joint cavitates (4) . Subsequently, superficial zone chondrocytes and type B synoviocytes continue to express lubricin throughout life (4, 5) . In patients with congenital (i.e., CACP) or acquired (e.g., inflammatory arthritis) deficiencies of lubricin, the synovial fluid fails to reduce friction in the boundary mode (6) .
Lubricin-knockout (Prg4 2/2 ) mice recapitulate some of the disease features observed in patients with CACP, such as noninflammatory synovial hyperplasia and precocious cartilage failure (4, 6) . Importantly, damage to the cartilage surface in lubricin-knockout mice is detectable by age 2 weeks, and a significant increase in whole-joint friction is evident by age 2 months (7). Thus, congenital absence of lubricin damages the cartilage surface and alters whole-joint mechanics early in life. However, complete cartilage failure can take a year to develop in Prg4 2/2 mice and decades to develop in patients with CACP (8) . Therefore, despite the absence of adequate boundary lubrication and the rapid appearance of joint damage, the progression to joint failure occurs at a much slower rate. This raises the possibility that any incipient traumatic event, such as ACL or meniscal injury, that causes cartilage surface damage will inevitably progress to cartilage failure over the long term (9) .
To determine whether the cartilage damage that results from congenital lubricin deficiency is treatable, we restored endogenous lubricin expression postnatally in lubricin-knockout mice. We created a strain of mice that have a reversible gene-trap (GT) in Prg4. This genetrap blocks lubricin expression; thus, upon Cre-mediated excision of the gene-trap, lubricin expression is restored. We restored lubricin expression in mice prior to conception or at ages 3 weeks, 2 months, or 6 months after birth, and evaluated the histologic features of the articular cartilage and the extent of whole-joint friction in these mice, compared to littermate mice whose gene function was not restored (nonrestored controls).
MATERIALS AND METHODS
Animal models. All animal studies were performed with the approval of the Institutional Animal Care and Use Committees at Boston Children's Hospital and Rhode Island Hospital.
Mice that are homozygous (Prg4
) for lubricin loss-of-function alleles have been described previously (4) . We generated mice with a new Prg4 allele (Prg4 GT ) (stock no. 025740; The Jackson Laboratory) (Figure 1 ). The Prg4 GT allele was created by homologous recombination in 129/SvEv ES cells ( Figure 1A) . The genetrap, which consists of a loxP-flanked artificial exon that contains a strong splice acceptor, a LacZ-coding sequence that is "in frame" with Prg4, an internal ribosome entry site, a reverse tetracycline trans-activator (rtTA) cassette, a polyadenylation site, and a neomycin selection cassette driven by its own promoter, was derived from the gene-trap secretory vector pTT1TM (10) . The Prg4
GT allele is designed to produce membrane-anchored b-galactosidase and rtTA, instead of lubricin, in cells in which Prg4 is normally expressed.
The artificial exon can be excised with Cre-recombinase (i.e., Prg4 GT R ) to restore lubricin expression. We used 2 different Cre-recombinase alleles to excise the gene-trap. One allele, Tg(eIIa-Cre) (stock no. 003724; The Jackson Laboratory), excises the gene-trap in the germline. The other allele, ROSA26
CreERt2 (stock no. 008463; The Jackson Laboratory), causes widespread excision of the gene-trap after injection of tamoxifen.
Standard animal husbandry was performed to generate cohorts of male and female mice. These mice, all on mixed B6/ 129 genetic backgrounds, had one of the following genotypes:
GT R =2 , and
Induction of Cre-mediated recombination using tamoxifen. Mice with the genotypes Prg4 
ROSA26
CreERt2/1 were given daily intraperitoneal injections of tamoxifen dissolved in corn oil (Sigma-Aldrich) at a dose of 0.1 mg/gm body weight for 10 consecutive days, beginning at ages 3 weeks, 2 months, or 6 months. The mice were then permitted to age normally until they were killed with CO 2 inhalation.
Sample collection and processing. The joints of mice were removed postmortem and processed immediately thereafter. Samples of the cartilage tissue for knee joint histology were fixed in 4% (weight/volume) paraformaldehyde (PFA) in phosphate buffered saline (PBS) overnight, and then rinsed several times in PBS and decalcified with either EDTA in PBS (14% w/v, pH 7.4) for ;2 weeks or a mild formic acid decalcifier (Immunocal; Decal) for 12 hours. Decalcified samples were again washed in PBS, and then dehydrated through a graded PBS-ethanol series, incubated in xylene, bisected in the sagittal plane with a razor, and infiltrated with paraffin. Sagittal sections (6 or 8 mm in thickness) were collected from the center of the bisected joint outward until the cruciate ligaments were no longer present, the tibial plateau became flattened, and the anterior and posterior portions of the meniscus were seen. Sections were stained with hematoxylin and eosin (H&E) in accordance with standard procedures (11) .
Samples for X-Gal staining were fixed briefly with 0.2% glutaraldehyde, 5 mM EDTA, and 2 mM MgCl 2 in PBS. The samples were then rinsed in PBS containing 2 mM MgCl 2 and 0.02% Nonidet P40. X-Gal staining was performed overnight in the dark with constant shaking in X-Gal staining solution (2 mg/ml X-Gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 , and 0.02% Nonidet P40 in PBS). Following staining, samples were washed in PBS, postfixed with PFA (4% w/v), and processed for histologic assessment in the same manner as described above.
Knee and femoral head cartilage samples were frozen in liquid nitrogen and homogenized in TRIzol (Invitrogen, Life Technologies) to recover RNA. For reverse transcription-polymerase chain reaction (RT-PCR) assays, RNA was isolated using a PureLink RNA Mini kit (Ambion) according to the manufacturer's instructions. Genomic DNA was removed by DNase I treatment. TaqMan RT reagents (Applied Biosystems, Life Technologies) were used to generate complementary DNA with oligo(dT). Semiquantitative PCR was performed using forward and reverse primers located within exons 7 and 9, respectively, since this region of Prg4 is downstream of the gene-trap and not subject to alternative splicing in wild-type mice. Gapdh served as an internal control. PCR products were separated on a 4% agarose gel and visualized using Sybr Safe (Invitrogen). RNA sequencing and data interpretation were performed as previously described (12, 13) .
Samples for biomechanical testing were harvested and soft tissue was removed around the tibiofemoral patellar joint, leaving the joint capsule intact. The whole-joint coefficient of friction (COF) was measured using a modified Stanton pendulum system, as previously described (7, 14, 15) . During pendulum oscillation, motion was tracked with a Qualysis OPUS camera and Track Manager software (Qualysis) at a rate of 60 Hz. Oscillation data were processed with Visual3D software (C-Motion), and a custom MatLab code (MathWorks) was used to determine the peak amplitude of each cycle of oscillation and calculate the COF using a Stanton linear decay model (14) .
Ex vivo cyclic loading was performed for 60 minutes, with the joint submerged in Dulbecco's modified Eagle's medi- Figure 1 . Generation of mice with a genetically engineered, Cre-excisable gene-trap (GT) in the second intron of Prg4. A, Schematic diagram depicting the genomic structure of the Prg4 wild-type (1), GT, and Cre-recombined GT (GT R ) alleles. The GT is flanked by loxP sites (thick black arrows), which enable removal of the GT with Cre-recombinase. B, X-Gal staining for b-galactosidase activity in sagittal sections from the tibiofemoral joints of 2-month-old Prg4 wild-type and homozygous GT mice. C, Semiquantitative reverse transcription-polymerase chain reaction (PCR) assessing Prg4 mRNA transcript expression, relative to Gapdh as control, using total RNA extracted from the joints of mice with genotypes containing different combinations of Prg4 wild-type, knockout (2), GT, and Cre-recombined GT alleles. The PCR primers are located downstream of the GT in Prg4 exons 7 and 9 (as indicated by red arrows in A). D, Photomicrographs showing X-Gal staining for b-galactosidase activity in the femoral heads from 1-month-old mice homozygous for Prg4 GT or Cre-recombined GT alleles. IRES 5 internal ribosome entry site; rtTA 5 reverse tetracycline trans-activator; pA 5 polyadenylation. um (Life Technologies) to prevent desiccation. Loading was achieved using an active pendulum that was continuously oscillated at an angle of 6158 and at a rate of 1.5 Hz, in 15-minute increments (7) . The whole-joint COF was measured at the end of each increment at room temperature in air. At the end of the loading experiment, each specimen was fixed in 10% formalin. Prior to immunostaining for activated caspase 3, each tissue specimen was decalcified at 48C using a solution of 0.48M EDTA, adjusted to a pH of 7.1. Decalcified specimens were paraffin embedded.
Quantitative histologic assessment of the joint cartilage. A tibiofemoral joint disease severity scoring system was devised based on several published scoring systems, including a scoring system from the Osteoarthritis Research Society International histopathology initiative (16) (17) (18) , and included evaluation of surface damage, cartilage surface layer morphology, synovial hyperplasia, chondrocyte proliferation, and meniscus architecture. An additional score for meniscus integrity was included. The scoring system is summarized in Supplementary Table 1 (available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39276/abstract). Photomicrographs of the sagittal knee sections obtained from mice with different Prg4 genotypes across several age groups were used to develop a training and reference set of images encompassing normal and diseased joints. Briefly, the knee sections were assessed for changes to surface morphologic features, synovial hyperplasia, chondrocyte proliferation, and meniscal architecture. The tibial plateau and the femoral condyle were scored separately. All samples were scored from H&E-stained sections. Three scientists (KAW, JMA, and GDJ), each of whom had received training on the scoring system, were sent 2 photomicrographs for each experimental animal. The scientists were blinded with respect to the animals' genotypes and treatment groups.
Activated caspase 3 immunostaining. Paraffin-embedded coronal sections (5 mm) were heated to 608C for 30 minutes, deparaffinized, and hydrated in 3 changes of xylene alternating with alcohol. Sections were quenched in endogenous peroxidase in 3% hydrogen peroxide for 10 minutes, and antigen retrieval was performed using a pepsin solution (Thermo Scientific) following the manufacturer's recommendations. A rabbit polyclonal antibody against active caspase 3 (ab13847; Abcam), at a 1:50 dilution in staining buffer containing 8% (volume/volume) horse serum, was added to the sections and incubated at 48C overnight. After 3 washes with PBS, the sections were incubated with Cy3-conjugated goat anti-rabbit IgG (Molecular Probes, Life Technologies), at a 1:50 dilution in staining buffer containing 8% (v/v) horse serum, for 1 hour at room temperature, protected from light. The sections were washed 5 times with PBS and counterstained using Vectashield mounting medium with DAPI (1.5 mg/ ml; Vector Laboratories).
Images were captured with a 10 3 objective, using a Roeper Scientific Photometrics CoolSNAP HQ2 monochrome camera connected to a Nikon Eclipse 90i microscope. Fluorescent images were set at a uniform threshold to reduce background autofluorescence and to adjust the DAPI signal, using Adobe Systems Photoshop CS5 software. Cells positive for activated caspase 3 were visualized at 1003 magnification, using Image-Pro Plus 7.0 software. Activated caspase 3-positive chondrocytes and DAPI-stained nuclei from the entire thickness of the mouse cartilage on the medial and lateral tibial plateaus and femoral condyles were manually counted by a blinded observer (KAW), using corresponding H&E-stained sections as a reference for cartilage depth. The overall percentage of activated caspase 3-positive chondrocytes among the total number of chondrocytes was reported.
Droplet digital PCR (ddPCR) assay of Cre-mediated recombination following tamoxifen administration in a 4-month-old mouse with the ROSA26 CreERt2 allele. Tamoxifen was administered for 8 consecutive days to a 4-month-old mouse that was double homozygous for conditional Pik3ca H1047R alleles (19) and ROSA26
CreERt2 alleles. The mouse was killed 2 days after tamoxifen administration, and DNA was extracted from multiple tissue samples, including tissue from the tail, cerebral cortex, and femoral head articular cartilage. A ddPCR assay (20) was used to quantify the fraction of cells in the different tissue samples that had undergone Cre-mediated recombination.
A PCR primer pair (CAAGGGAGAGGAATGG-TAAGG and CAACTCAGGCATGCCGGATCCCAA) was used to generate a 719-bp amplimer from the conditional allele and a 265-bp amplimer from the recombined alleles. In addition, the PCR mixture contained fluorescent probes that detect the recombined allele (FAM-CGAAGTTATGT-TAACTTGTTAGACC-IABk) or the conditional allele (HEX-CGAAGTTATTTGTTAGACCCTT-IABk). Seven nanograms of each DNA sample was tested in duplicate in 20-ml reaction mixtures that were emulsified into ;14,000 droplets using a QX100 Droplet Generator (Bio-Rad), according to the manufacturer's instructions. PCR was performed with the following parameters: 10 minutes at 958C, followed by 40 cycles of 30 seconds at 948C, 60 seconds at 558C, and 120 seconds at 728C, and then kept at 128C. Samples were read using a QX100 Droplet Reader, and results were analyzed with QuantaSoft software (both from Bio-Rad).
Statistical analysis. Statistical analyses of whole-joint COFs, with comparisons between genotypes and between cyclic loading durations, were performed using two-way repeated-measures analysis of variance (ANOVA) (a 5 0.05) with Tukey's multiple comparison test, using GraphPad Prism statistical software (version 6). For statistical analyses of total joint histologic scores, the mean values of the 3 scientists' scores for each mouse were used. Total joint histologic scores were compared between genotypes, treatment groups, and time points, using the MannWhitney U test for nonparametric data, given the lack of normality of the data and because these values represent scores rather than continuous data. Interobserver agreement in histologic scores was measured with the intraclass correlation coefficient (ICC) with 95% confidence interval (95% CI). Statistical analyses were performed using IBM SPSS statistical software (version 21.0). Two-tailed P values less than 0.05 were considered significant. Comparisons of the percentage of activated caspase 3-positive cells between different genotypes were analyzed using one-way ANOVA (a 5 0.05) with Tukey's multiple comparison test, using GraphPad Prism statistical software (version 6). Due to their functional equivalence, the Prg4
, and Prg4 2/2 genotypes were combined into a single group for the purposes of statistical analyses, as were the Prg4 1/2 , Prg4
, and Prg4 GT/GT mouse cartilage ( Figure  1B) . Furthermore, Prg4
GT/GT mice did not express wildtype Prg4 messenger RNA (mRNA), as indicated by RT-PCR using Prg4 primers in exons that are downstream of the gene-trap ( Figure 1C To determine whether Cre-mediated excision of the gene-trap restored endogenous Prg4 mRNA expression, we excised the gene-trap in germ cells using the Tg(eIIa-Cre) allele to generate mice with a Prg4 Figure 1C ) and no longer expressed b-galactosidase ( Figure 1D ). We performed RNA sequencing on the knee joint cartilage from 2-and 3-week-old Prg4 Figure 2 . The Prg4 gene-trap (GT) allele is a loss-of-function allele whose function is fully restored following Cre-mediated excision. A, Hematoxylin and eosin (H&E) staining of the tibiofemoral joints from 2-month-old Prg4 homozygous knockout (2/2) and compound heterozygous GT/knockout (GT/2) mice. Arrows indicate protein deposition along the cartilage surface, consistent with lubricin deficiency. B, H&E staining of the tibiofemoral joints from 2-month-old Prg4 heterozygous knockout (1/2) and compound heterozygous Crerecombined GT/knockout (GT R /2) mice. The articular cartilage in these mice appears to be normal, in that the superficial zone chondrocyte nuclei are located adjacent to the cartilage surface, the internal edges of the menisci are sharp, and there is no protein deposition along the surface. Original magnification 3 100. Table 1 .
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Prg4
GT R =GT , and Prg4 1/GT mice, and confirmed that the GT allele is a null allele (see Supplementary Figures 1A and B, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art. 39276/abstract). We also confirmed that the abundance of the GT R allele (see Supplementary Figure 1B ) and the splice forms from the GT R allele (data not shown) are the same as those from the wild-type allele.
Identification of the Prg4 GT allele as a loss-offunction allele, and the Prg4 mice revealed similar histopathologic changes to the cartilage in both genotypes (Figure 2A) , consistent with the notion that the Prg4 GT allele prevents lubricin expression. Conversely, the histologic appearance of the cartilage of Prg4 1/2 and Prg4 GT R =2 mice was normal ( Figure 2B ), both being indistinguishable from that of wild-type mouse cartilage, indicating that Prg4
GT R functions in a manner similar to a wild-type allele. Moreover, in mice at age 2 months, protein deposition was apparent on the cartilage surface in both the Prg4
2/2 and Prg4
GT/2 genotypes, but was not apparent in either the Prg4 1/2 or Prg4 GT R =2 genotype (Figures 2A and B) .
Consistent with the abnormal appearance of the articular cartilage of lubricin-deficient mice, these mice (i.e., mice with the Prg4 GT/GT or Prg4 GT/2 genotype) had higher whole-joint COFs compared to lubricin-sufficient mice (i.e., mice with the Prg4 1/2 or Prg4 GT R =GT genotype) ( Figure 3A and Table 1 ). In addition, the joints of lubricin-deficient mice exhibited a progressive increase in the COF during ex vivo cyclic loading, whereas the joints of lubricin-sufficient mice showed no notable changes in the COF during ex vivo cyclic loading ( Figures 3A and B) . The total joint histologic scores assessed in the knees of 150 mice with different Prg4 genotypes and ages (data not shown) were used to determine the ICC among the 3 scorers. The ICC was 0.922 (95% CI 0.897-0.941), indicating high correlation of scores. As expected, the total joint histologic scores were significantly better in 2-month-old lubricin-sufficient mice (i.e., Prg4 1/2 and Prg4 GT/1 mice) than in lubricindeficient mice (i.e., Prg4
GT/GT , Prg4 2/2 , and Prg4
GT/2 mice) ( Figure 3C and Table 1 ). Moreover, the total joint histologic scores of lubricin-deficient mice significantly worsened from ages 2 months to 6 months and from ages 6 months to 9 months ( Figure 3C and Table 1 ). In contrast, no worsening in the total joint histologic score was observed in lubricin-sufficient mice when they were examined from ages 2 months to 6 months (P 5 0.628), although there was greater variability in the total joint histologic scores of the 6-month-old lubricin-sufficient mice ( Figure 3C and Table 1 ). Partial histologic and biomechanical benefit of restoring lubricin expression in 3-week-old mice.
Having demonstrated that reversing the Prg4
GT allele (i.e., Prg4 GT R ) prior to conception prevented cartilage damage, we next determined whether restoring lubricin expression after birth would be beneficial. To induce Cre-mediated excision of the gene-trap after birth, we utilized the ROSA26 CreERt2 allele. We generated Prg4
GT/1 , Prg4 GT/GT , and Prg4 GT/GT ;ROSA26
CreERt2/1 mice, and at age 3 weeks, the mice received 10 daily /GT, or 1/GT; lubricin-deficient (LD) 5 2/2, GT/2, or GT/GT; GT R3w 5 gene-trap reversed at age 3 weeks; GT R2m 5 gene-trap reversed at age 2 months; and GT R6m 5 gene-trap reversed at age 6 months. The coefficient of friction was measured without ex vivo cyclic loading (time 5 0), and P values were determined by 2-tailed analysis of variance (ANOVA). P values for comparisons of the total joint histologic scores were determined by nonparametric MannWhitney U test. P values for comparisons of the percentage of activated caspase 3-positive chondrocytes were determined by one-way ANOVA. P values less than 0.05 were considered significant. Figure 4 . Restoring Prg4 expression in 3-week-old mice may delay, but does not prevent, histopathologic appearance of cartilage damage. A and B, Hematoxylin and eosin (H&E) (A) and X-Gal (B) staining of cartilage sections from the tibiofemoral joints of 2-month-old mice homozygous for the gene-trap (GT) allele or homozygous for a GT allele that had been Cre-excised at age 3 weeks (GT R3w/ GT R3w ). Arrowheads indicate that some regions of the synovium still express LacZ, providing evidence that Cre-mediated recombination of the GT allele in synovium is incomplete. C, H&E staining of cartilage sections from the joints of 6-month-old GT/GT or GT Table 1 .
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HILL ET AL intraperitoneal injections of tamoxifen or vehicle alone. Thereafter, when the mice reached ages 2 months and 6 months, we examined the knee joints biomechanically using whole-joint COFs ( Figures 3A and B and Table  1) , and histologically using total joint histologic scores and immunostaining ( Figures 3C and 4A -D, and Table  1 ). We confirmed that 10 days of tamoxifen injections led to efficient excision of the gene-trap in the superficial zone chondrocytes of Prg4 GT/GT ;ROSA26
CreERt2/1 mice, as indicated by X-Gal staining of the cartilage sections from mice at age 2 months ( Figure 4B ).
After the Prg4
GT/GT ;ROSA26 CreERt2/1 mice had been treated with tamoxifen at age 3 weeks, the joints of these mice (i.e., Prg4
GT
R3w =GT R3w mice) had lower COFs at age 2 months (P , 0.003) and trended toward having better-appearing cartilage based on histologic features and lower total joint histologic scores (P 5 0.062) compared to lubricin-deficient mice (Figures 3A-C and Table 1 ). The histologic appearance nevertheless appeared worse than that of mice with an inherited functional allele (e.g., Prg4
1 and Prg4 GT R ) ( Figures 2B, 3C , and 4), but this difference did not achieve statistical significance (Table 1) .
Biomechanical testing showed that restoring lubricin expression in mice at age 3 weeks resulted in a significant reduction in the COF compared to that in littermates with nonfunctional alleles. Moreover, the COF increased in mice with restored lubricin expression at age 3 weeks as compared to mice with inherited func- Figure 5 . Restoring Prg4 expression in mice at age 2 months does not improve the histologic appearance of the articular cartilage. A-C, Hematoxylin and eosin staining of cartilage sections from the tibiofemoral joints of a 6-month-old heterozygous gene-trap (GT) mouse (A), a homozygous GT mouse (B), and a mouse whose GT was Cre-excised at age 2 months (GT R2m /GT R2m ) (C). Original magnification 3 40 (top panels) and 3 200 (bottom panels). D, Immunostaining for activated caspase 3 following 60 minutes of ex vivo cyclic loading of the joints of a 6-monthold lubricin-sufficient mouse (GT R /2), a lubricin-deficient mouse (GT/GT), and a GT R2m /GT R2m mouse. Cell nuclei are labeled with DAPI. Arrowheads indicate examples of chondrocytes that are positive for activated caspase 3. Bars 5 100 mm. Cohort sizes and P values for betweengroup comparisons of the percentages of activated caspase 3-containing chondrocytes are reported in Table 1. tional alleles, but the difference was not significant (Figures 3A and B) . Interestingly, however, in contrast to that in mice with inherited functional alleles, ex vivo cyclic loading of the joints of Prg4
R3w =GT R3w mice was associated with a progressive increase in the COF ( Figure 3B) .
We then determined the percentage of chondrocytes that were positive for activated caspase 3 following cyclic loading. We found that significantly fewer cells exhibited activated caspase 3 in Prg4
R3w =GT R3w mice compared to lubricin-deficient littermates ( Figure 4D and Table 1 ). In addition, we observed no difference in the percentage of activated caspase 3-positive chondrocytes between Prg4
R3w =GT
R3w and Prg4
GT R =2 mice (P 5 0.96).
In Prg4
mice at age 6 months, the joint COF became higher than that in mice with inherited functional alleles. When compared to lubricin-deficient mice, the COF in Prg4
GT
R3w =GT R3w mice at age 6 months was not significantly different ( Figure 3B and Table 1 ). However, the joints of 6-month-old Prg4
mice did not show a progressive increase in the COF with cyclic loading, in contrast to that in their lubricin-deficient littermates ( Figure 3B ), and the percentage of activated caspase 3-positive chondrocytes in the cyclically loaded joints of 6-month-old Prg4
mice was lower than that in the cyclically loaded joints of lubricindeficient mice (Table 1) . However, we could no longer detect a quantifiable improvement in the histopathologic features of the articular cartilage of 6-month-old Prg4
R3w
mice as compared to lubricin-deficient mice ( Figures 3C and 4C , and Table 1 ).
Lack of histologic or biomechanical benefit from restoring Prg4 expression in 2-month-old mice. Having found partial benefit from restoring gene expression in 3-week-old mice, we next restored gene expression in 2-month-old mice (i.e., Prg4
GT
R2m =GT R2m mice). When the mice reached age 6 months, we examined their joints histologically and biomechanically. Cartilage histologic features, the whole-joint COF, and the percentage of cells positive for activated caspase 3 were no better in Prg4
mice than in lubricindeficient mice (Figures 3 and 5 , and Table 1) , with most of the activated caspase 3-positive cells located in the middle, rather than superficial, articular cartilage zone. Similarly, we observed no histologic benefit of restoring lubricin expression in the joints of these mice at age 6 months when examined at age 9 months ( Figure 3C and Table 1 ).
Similar to the findings reported by other investigators (21) Figure 1C ).
DISCUSSION
Degenerative joint disease is common (22, 23) . In the context of a severe joint injury, the initiating event is known (24, 25) . However, in most patients with osteoarthritis, the incipient event, if one exists, is not known. We used a genetic mouse model of progressive joint failure (i.e., lubricin-deficient mice), caused by inadequate boundary lubrication at the cartilage surface, to determine whether cartilage damage can be ameliorated by restoring the boundary lubricant and, if so, whether there is a window of opportunity for successfully intervening. These questions are of primary importance for the management of patients with CACP, who have congenital lubricin deficiency, and may be important for individuals with acquired deficiency of lubricin, as can occur during injury, infection, and inflammatory disease (26) .
We restored lubricin expression in lubricindeficient mice using a Cre-excisable Prg4 gene-trap (Figure 1) . We first showed that removal of the gene-trap recreates a wild-type allele (Figure 2 ). We then evaluated mice in which we removed the gene-trap at age 3 weeks, and observed an improved, but not normal, histologic appearance of their tibiofemoral cartilage at age 2 months (Figures 3 and 4) . The whole-joint COF in these mice was also improved, but not normalized, at age 2 months ( Figure 3) ; however, we could no longer detect an overall improvement in the histologic appearance or in the COF of the articular cartilage of 6-month-old mice (Figures 3 and 4) . The histologic appearance of the joints, or at least the total joint histologic scoring system that we used, may not accurately reflect joint function in these mice, since even lubricinsufficient mice developed higher and more variable joint disease severity scores as they aged. Biomechanical function during cyclic loading along with measurement of activated caspase 3 may provide a more sensitive method for assessing the effect, or lack thereof, of lubricin restoration (Figures 3 and 4) . Based on biomechanical testing and activated caspase 3 staining, restoring 3078 HILL ET AL lubricin expression in 3-week-old mice produced some beneficial effect. Restoring lubricin expression in 2-month-old mice produced no apparent benefit (Figures 3 and 5) . These data imply that the therapeutic window of opportunity for preventing irreversible cartilage damage in congenital lubricin deficiency is small, at least in this animal model. The relationship of therapeutic windows between mice and humans is unknown. However, it seems likely that early intervention will be required in order to prevent or delay cartilage failure in patients with CACP.
Recent findings indicate that lubricin may promote cell preservation by providing anabolic signaling (27) and preventing apoptosis. A significant reduction in the percentage of activated caspase 3-positive cells in mice subjected to Cre-mediated recombination at age 3 weeks, as compared to that in lubricin-deficient mice, indicates that cellular protection is reestablished following recombination. As the sole cell type in cartilage, chondrocytes play specialized roles in the maintenance of the cartilage extracellular matrix. The majority of activated caspase 3-positive chondrocytes were rounded and were found in the upper middle zone, located just below the flattened superficial chondrocytes. Based on previous findings in bovine cartilage (28) (29) (30) and studies regarding the structure of collagen in mouse cartilage (31), we hypothesize that the junction of tangential to columnar type II collagen bundles in this region results in elevated cartilage strain that damages rounded chondrocytes, which are not designed to withstand shear stress. Furthermore, elevated stress may contribute to a number of transduction pathways, including the expression of catabolic and apoptotic factors (32) (33) (34) (35) (36) (37) (38) (39) , which accelerate cartilage deterioration in the disease state.
Our results may be relevant to common forms of degenerative joint disease. Excessive friction has been shown to cause apoptosis in bovine cartilage bearings (15, 40) . We observed excessive caspase 3 activation following cyclic loading in lubricin-deficient mice (Figures 4 and 5, and Table 1 ) and in gene-trap mice whose lubricin expression was restored at age 2 months ( Figure 5 ). Thus, patients with a transient deficiency of boundary lubrication may sustain cartilage damage that will progress, even after the lubricin levels have returned to normal.
If transiently increased friction within a joint is an incipient event for degenerative joint disease, then strategies for preventing or rapidly reducing friction are needed. Five published studies have demonstrated beneficial effects of administering lubricin following joint injury in animal models (41) (42) (43) (44) (45) . However, each of these studies had limited followup-between 28 days and 70 days following joint injury-and, therefore, it remains uncertain whether adding lubricin would really prevent, or might only delay, joint failure. Interestingly, constitutive overexpression of lubricin has been demonstrated to prevent cartilage damage in a mouse model of traumatic joint injury, although the length of followup was ,6 weeks (27) .
The strength of our study is in its genetic approach. By placing the gene-trap into the Prg4 locus, we were able to restore endogenous lubricin mRNA expression when the gene-trap was excised. Moreover, since lubricin mRNA has several different splice forms, our genetic approach restored expression of all forms. However, we could not demonstrate that lubricin protein was produced when the gene-trap was excised, since we have not been able to generate antibodies (46) or find a commercially available antibody that reliably immunodetects mouse lubricin when Prg4 2/2 mice are used as an appropriate negative control. Instead, we inferred that protein was being expressed on the basis of the observed normal phenotypes of Prg4 GT allele had been Cre-excised (Figure 4 ). There are several limitations to our study. First, some cohorts were underpowered to achieve statistical significance. Faster and more reliable imaging techniques are being developed to assess cartilage morphology, which should make studies involving larger sized cohorts more feasible.
Second, scattered areas of b-galactosidase expression were still present in the synovium of treated mice, indicating that we had not restored lubricin expression in every type B synoviocyte. Therefore, we may not have attained normal lubricin levels in the synovial fluid.
Third, the genetic background of the mice used in this study was mostly C57BL/6J, a background in which full-thickness cartilage defects are known to heal less well than in other strains of mice (47) . Therefore, mice with other genetic backgrounds might have had better responses to lubricin reexpression.
Finally, despite having an ICC of .0.9, the histologic scoring system used in the present study may be insensitive with regard to detection of chondroprotective effects. In a study of preclinical rodent OA lubricin supplementation, a modified Mankin histologic scoring system failed to show improvement of cartilage damage, but levels of urine type II collagen degradation products were significantly lower in the rodents treated with exogenous lubricin (42) . Longer-term followup and more sensitive measures of joint structure and function may be needed to better assess therapeutic outcomes.
Future work is also needed to determine whether restoration of lubricin expression in mice younger than age 3 weeks can reverse disease or prevent disease progression. It is possible that lubricin assumes a critical function during joint cavitation that is irreplaceable after birth, although the cartilage of newborn lubricindeficient mice appeared normal by electron microscopy (6) . In addition, the present studies were performed in mice that had congenital deficiency of lubricin, as is also seen in patients with CACP. Studies in mice in which the joints had formed when lubricin was sufficient and which then developed a transient deficiency would better inform us regarding the importance of preventing transient deficiency in traumatic injuries and inflammatory disorders.
Thus, our data suggest that early restoration of lubricin expression may slow disease progression in patients with CACP, a condition in which individuals congenitally lack this protein. Further studies are required to determine the relevance of our findings in the management of patients experiencing transient acquired deficiency of lubricin due to traumatic injury or inflammation.
